CXP Commerce Experts GmbH – Trademark Portfolio
Entity Type: 99
CXP Commerce Experts GmbH holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NEURALINFUSION. The owner is based in Pforzheim.
Am Schoßgatter 3
Pforzheim 75172 , DE
Showing of trademarks Trademarks
Trademark Classifications
CXP Commerce Experts GmbH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does CXP Commerce Experts GmbH have?
CXP Commerce Experts GmbH has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does CXP Commerce Experts GmbH file in?
CXP Commerce Experts GmbH files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are CXP Commerce Experts GmbH's most well-known trademarks?
CXP Commerce Experts GmbH's registered trademark portfolio includes well-known marks such as NEURALINFUSION. These are among 1 currently registered trademark in the portfolio.
What is CXP Commerce Experts GmbH's trademark registration success rate?
CXP Commerce Experts GmbH has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.